|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-3-2
|
|
pubmed:abstractText |
One of the goals of study AMA-BFM-87 was to test prospectively in acute myelogenous leukemia (AML) patients if cranial irradiation could be replaced by late intensification therapy with high-dose cytarabine (Ara-C) and etoposide (VP-16).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
279-86
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8426205-Adolescent,
pubmed-meshheading:8426205-Bone Marrow,
pubmed-meshheading:8426205-Brain Neoplasms,
pubmed-meshheading:8426205-Child,
pubmed-meshheading:8426205-Child, Preschool,
pubmed-meshheading:8426205-Cranial Irradiation,
pubmed-meshheading:8426205-Female,
pubmed-meshheading:8426205-Humans,
pubmed-meshheading:8426205-Leukemia, Myeloid, Acute,
pubmed-meshheading:8426205-Life Tables,
pubmed-meshheading:8426205-Male,
pubmed-meshheading:8426205-Multivariate Analysis,
pubmed-meshheading:8426205-Prospective Studies,
pubmed-meshheading:8426205-Recurrence,
pubmed-meshheading:8426205-Regression Analysis,
pubmed-meshheading:8426205-Risk
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87.
|
|
pubmed:affiliation |
University Children's Hospital, Münster, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
